State IN
Clinical Trials in Indiana
Recruiting clinical trials with at least one study location in Indiana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Indiana
NCT05373017 N/A
Recruiting
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivo...
Condition
Delirium
Enrollment
528 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT06807268 Phase 3
Recruiting
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years o...
Condition
Eczema
Enrollment
150 pts
Location
United States, China, Germany
Sponsor
Pfizer
NCT05010603 N/A
Recruiting
Late Onset Alzheimer's Disease
Condition
Alzheimer Disease
Enrollment
10,000 pts
Location
United States
Sponsor
Columbia University
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
NCT06859970 N/A
Recruiting
An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Im...
Condition
Heart Failure
Enrollment
20 pts
Location
United States
Sponsor
InterShunt Technologies, Inc.
NCT06863129 N/A
Recruiting
Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Tria...
Condition
Metastatic Bone Disease
Enrollment
334 pts
Location
United States, Belgium, Brazil
Sponsor
Michelle Ghert, MD
NCT04592445 N/A
Recruiting
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having H...
Condition
Heart Failure With Preserved Ejection Fraction (HFpEF
Enrollment
150 pts
Location
United States
Sponsor
Axon Therapies, Inc.
NCT06897475 Phase 2
Recruiting
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes ...
Condition
Type 2 Diabetes
Enrollment
240 pts
Location
United States, Canada, Germany
Sponsor
Eli Lilly and Company
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT05112601 Phase 2
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System...
Condition
Endometrial Adenocarcinoma
Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05544266 N/A
Recruiting
Rare and Atypical Diabetes Network
Condition
Diabetes Mellitus
Enrollment
2,000 pts
Location
United States
Sponsor
University of South Florida
NCT04485559 Phase 1
Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients Wi...
Condition
Recurrent World Health Organization (WHO) Grade II Glioma
Enrollment
50 pts
Location
United States
Sponsor
University of California, San
NCT04337177 Phase 1
Recruiting
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatm...
Condition
Solid Tumors
Enrollment
20 pts
Location
United States
Sponsor
Valent Technologies, LLC
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT05367609 N/A
Recruiting
Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion ...
Condition
PPAP
Enrollment
300 pts
Location
United States
Sponsor
Senthil Sadhasivam
NCT05633667 Phase 2
Recruiting
Study of Novel Treatment Combinations in Patients With Lung Cancer
Condition
Lung Cancer
Enrollment
270 pts
Location
United States, Brazil, Hong Kong
Sponsor
Gilead Sciences
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT04996628 N/A
Recruiting
Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response fo...
Condition
Chronic Pancreatitis
Enrollment
150 pts
Location
United States
Sponsor
University of Pittsburgh
NCT06491030 Phase 4
Recruiting
Post-Operative Thoracolumosacral Orthosis for PJK
Condition
Proximal Junctional Kyphosis
Enrollment
84 pts
Location
United States
Sponsor
Hospital for Special Surgery,
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT06717698 Phase 2
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130...
Condition
Chronic Kidney Disease
Enrollment
465 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT07207811 Phase 3
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine...
Condition
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Enrollment
1,280 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S